Search
Close this search box.

Agresta joining OnKure as CMO

ARTICLE | Management Tracks

Plus: Viridian hires Tousignant and an update from Ligand

By Richard Guy, Biopharma Analyst

February 17, 2024 12:56 AM UTC

Cancer company OnKure Inc. hired Samuel Agresta as CMO. Agresta was CMO at Foghorn Therapeutics Inc. (NASDAQ:FHTX).

Viridian Therapeutics Inc. (NASDAQ:VRDN) hired Jennifer Tousignant, former SVP of legal at Sana Biotechnology Inc. (NASDAQ:SANA), as chief legal officer. Viridian is developing IGF1R-targeting antibody VRDN-001 to treat thyroid eye disease. …